Skip to main content
Clinical Trials/CTRI/2022/02/040119
CTRI/2022/02/040119
Not yet recruiting
未知

A comparative study of chemical sphincterotomy (using 2% diltiazem) and lateral internal sphincterotomy for chronic anal fissure: open label randomized control trial

Dr Nitin Sherkar0 sites0 target enrollmentStarted: TBDLast updated:

Overview

Phase
未知
Status
Not yet recruiting
Sponsor
Dr Nitin Sherkar

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • a)ALL PATIENTS WHO WILL PRESENT IN SURGICAL OUT\-PATIENT DEPARTMENT WITH COMPLAINTS OF PAINFUL PASSAGE OF STOOL, WITH OR WITHOUT BLEEDING OF MORE THAN 6 WEEKS DURATION, DIAGNOSED TO BE HAVING CHRONIC ANAL FISSURE BASED ON THE HISTORY AND ON CLINICAL EXAMINATION.
  • b)ALL PREVIOUSLY DIAGNOSED CASES OF ACUTE ANAL FISSURE WHO ARE TAKING STOOL SOFTENER AND MEDICATIONS FOR MORE THAN 6 WEEKS

Exclusion Criteria

  • PATIENTS OF CHRONIC ANAL FISSURE ASSOCIATED WITH
  • a)TUBERCULOSIS
  • b)HAEMORRHOIDS
  • c)ANORECTAL ABSCESSES
  • d)ANAL MALIGNANCIES
  • e)IMMUNOCOMPROMISED PATIENTS
  • f) PREVIOUS HISTORY OF FAECAL INCONTINENCE OR ANAL STENOSIS
  • g) PATIENTS WHO HAVE UNDERGONE PREVIOUS ANAL SURGERIES
  • h)PATIENTS WITH HISTORY OF BLEEDING

Investigators

Sponsor
Dr Nitin Sherkar

Similar Trials